SPOTLIGHT: Amgen pays CEO 29 percent less

It's a pay cut for Amgen Chairman and CEO Kevin Sharer (photo). His 2007 compensation dropped by nearly 29 percent to $13.2 million, from $18.6 million in 2006. The 2007 number includes $1.5 million in salary and $1.5 million in bonuses (which came to $4.5 million the previous year). His stock and options were valued at $9.3 million by the Associated Press, compared with $11.65 million in 2006. Report | Report

Suggested Articles

Intercept presented a data analysis that found treatment with Ocaliva led to "early and consistent improvements" in a range of noninvasive tests.

Intent-driven audiences are inspired to make health-improving changes after a positive online experience. Find out what they’re driven to do.

Days before Amarin faces a pivotal FDA vote on its Vascepa expansion, advisors are set to scrutinize the placebo used in its pivotal outcomes trial.